Prot# C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis

Project: Research project

Project Details

StatusActive
Effective start/end date8/30/188/30/21

Funding

  • CTI Clinical Trial and Consulting Services (Prot# C928-010)
  • DURECT Corporation (Prot# C928-010)